Nestlé plans $2.8B savings, boosts marketing to 9% of sales, and reorganizes for growth under new CEO.

Novo Nordisk's Ozempic, a weight loss drug originally developed for diabetes, has become a market phenomenon with $14 billion in sales in 2023, despite facing legal challenges and scrutiny over its pricing and side effects, while the company continues to expand its reach through acquisitions and new drug developments.

Spirit Airlines filed for Chapter 11 bankruptcy protection as it struggles with over $2.5 billion in losses since 2020, mounting debt, and increased competition, while securing financial support from bondholders to restructure its operations and continue normal services.